<DOC>
	<DOCNO>NCT01038700</DOCNO>
	<brief_summary>This part project aim describe change marker vascular competence ( Endothelial Microparticles Platelet ( EMP ) , Circulating endothelial cell ( CEC ) Circulating endothelial progenitor ( EPC ) ) different age lifespan physiological state response hypoxia-induced vascular stress .</brief_summary>
	<brief_title>Circulating Endothelial Compartment During Normal Pathological Aging</brief_title>
	<detailed_description>Blood harvest citrate EDTA anticoagulant process within one hour Endothelial Microparticles Platelet ( EMP ) , Circulating endothelial cell ( CEC ) Circulating endothelial progenitor ( EPC ) determination . Methods endothelial marker determination : - Endothelial Microparticles Platelet free plasma ( PFP ) prepare double step centrifugation citrate blood 1,500g 15 min 13,000 g 2 min room temperature . Then EMP enumerate flow cytometry label PFP use monoclonal antibody direct endothelial antigen , CD144 ( 19 ) . To investigate proportion EMP within whole circulate MP , MP platelet , leukocyte erythrocyte origin determine use respectively , CD41 , CD45 , Glycophorin-directed antibody , total number phosphatidylserine express MP determine use AnnexinV binding . - CEC enumerate use consensual methodology base immunomagnetic separation assay ( 20 ) . CEC isolate EDTA whole blood use magnetic bead coat antibody direct CD146 antigen . Isolated cell identify use additional criterion morphology , size high 15µm , cell rosette bear 5 bead , expression endothelial marker ( lectin binding ) . - For EPC two complementary approach use determination : 1 . Flow cytometry direct immunolabelling whole blood mononuclear cell fraction use monoclonal antibody viability marker 7AAD . Due lack specific marker EPC great heterogeneity cell recover feature EPC21 flow cytometry analysis include numeration different cell population correspond differentiation state EPC : CD34+CD133+ cell CD34+KDR+ cell . The circulate haematopoietic progenitor CD34+CD45+ also numbered.- 2 . Clonogenic assay allow numeration Colony Forming Unit ex vivo culture EPC include : - CFU-EC , EPC myeloid subtype ( also call early EPC ) determine accord previously describe method Hill et al . The non-adherent fraction mononuclear cell plat fibronectin coated dish Endocult® medium . number endothelial colony count 48h culture - High Proliferative Potential CFU , true angioblasts determine Ingram 's method ( 21 ) . Mononuclear cell plat fibronectin-coated plate EGM-2MV culture medium late EPC colony enumerate 10-15 day culture . - three-dimension methyl cellulose assay added growth factor VEGF . The CFU-EC number 14 day usually perform haematopoietic stem cell . Effect hypoxia equilibrium endothelial damage repair According Ingram , normal vascular endothelium contain high proliferate potency EPC ( 22 ) suggest late EPC may also originate vessel wall . In addition , local hypoxia might also mobilize EPC ( 23 ) . We design protocol specific aim 1/ test effect local hypoxia marker endothelial damage/repair equilibrium 2/ define whether elderly patient , local ischemia use mobilize EPC increase proliferation potential compare EPC isolate rest condition . Two group healthy volunteer age 20-30 60-70 year cohort submit forearm transient ischemia describe Friedrich et al ( 23 ) . Peripheral blood sample obtain 10 min venous occlusion perform cuff pressure midway systolic diastolic pressure ( 24 ) . EPC , CEC EMP enumerate accord method describe supra EPC test proliferate capacity time point . The arterial phenotype conduct artery evaluate , acute flow-mediated vasodilatation ( FMD ) endothelium-independent vasodilatation ( EIV ) brachial artery ( BA ) young old healthy volunteer use high-resolution echotracking system . The efficiency venous occlusion evaluate release t-PA endothelial cell .</detailed_description>
	<criteria>Healthy volunteer 2030 6070 year old Non smoker male Biological test normal value : lipid , glucose , TGO , TGT , alkaline phosphatase , gammaGT , bilirubin , creatinine , ionogram , Ca++ , albumin , protein , WBC , platelets count , coagulation test ( APTT , PT , Fibrinogen ) . Negative HIV1 2 , HBV ( Hbs antigen ) HCV serology . Normal ECG 12 derivation , arterial pressure cardiac frequency . Evaluative disease past 10 day Hemorrhagic disorder Treatments antiplatelets agent , oral injectable anticoagulant Statins , glitazones , EPO , GCSF Frequent faintness Blood donation 3 month precede study People period exclusion National File people lend biomedical research Refusal linguistic psychic incapacity sign enlighten consent Biological parameter apart usual value healthy subject ( Hb &lt; 10 g/dL , TGO/TGT &gt; 2 time higher limit normal value ) Prone able subject constraint protocol ( example , cooperate , incompetent go visit followup probably incompetent finish study ) .</criteria>
	<gender>Male</gender>
	<minimum_age>10 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>September 2015</verification_date>
	<keyword>Circulating endothelial compartment</keyword>
	<keyword>microparticles</keyword>
	<keyword>endothelial progenitor cell</keyword>
	<keyword>circulate endothelial cell</keyword>
	<keyword>transcriptome</keyword>
	<keyword>age</keyword>
	<keyword>Healthy volunteer</keyword>
</DOC>